Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Forum of Clinical Oncology
Volume 7 (2016): Issue 2 (June 2016)
Open Access
Cardiotoxicity of the adjuvant trastuzumab in a Saudi population: clinical experience of a single institution
Rasha Hamdy Hamed
Rasha Hamdy Hamed
,
Khalid Salim
Khalid Salim
,
Abdullah Alzahrani
Abdullah Alzahrani
and
Shereef Elsamany
Shereef Elsamany
| Dec 30, 2016
Forum of Clinical Oncology
Volume 7 (2016): Issue 2 (June 2016)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Dec 30, 2016
Page range:
1 - 6
Received:
Feb 23, 2016
Accepted:
Oct 14, 2016
DOI:
https://doi.org/10.1515/fco-2016-0007
Keywords
Cardiotoxicity
,
Adjuvant trastuzumabin
,
Breast cancer
© 2016 De Gruyter Open
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.